Alaunos Therapeutics, Inc. (TCRT) News
Follow Alaunos Therapeutics, Inc. (TCRT) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 5 public stories across 2 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
Alaunos Acquires Velaris in $350 Million Private Placement
Alaunos Therapeutics reported the acquisition of Velaris Therapeutics and a $350 million private placement led by Fairmount. Its shares more than doubled to $2.92.
EQUITY | Oct 13, 2026, 06:24 PM UTC
L
Alaunos Therapeutics Announces Acquisition of Velaris Therapeutics
MNA | Oct 13, 2026, 02:38 PM UTC
M
Alaunos Acquires Velaris in Stock Merger, Secures $350 Million PIPE
Alaunos Therapeutics completed a stock-for-stock acquisition of Velaris and signed a $350 million PIPE to fund development of Velaris programs.
EQUITY | Oct 13, 2026, 01:34 PM UTC
M
Paragon Labs adds former Apogee executives; Alaunos acquires Velaris Therapeutics
The alert reports leadership-team additions at Paragon Labs and an acquisition of Velaris Therapeutics by Alaunos Therapeutics, Inc. It provides no further details.
EQUITY | Oct 13, 2026, 11:00 AM UTC
L
TCRT - Alaunos Therapeutics, Inc. Announces Pricing of Registered Direct Offering priced at-the-market under Nasdaq rules
TCRT - Alaunos Therapeutics, Inc. Announces Pricing of Registered Direct Offering priced at-the-market under Nasdaq rules
NEWS | Sep 18, 2026, 01:00 PM UTC